However, compared to the FAST‐treated groups, the depletion of CD4+ T or CD8+ T cells partially diminished the anti‐tumor effect of FAST (Figure 2D,E), suggesting that both CD4+ T and CD8+ T cells play critical roles in suppressing tumor progression in the FAST treatment group. Here, CD4 is linked to neoplasm.